Editorial & Opinion
Multi-treatment resistance to biological treatment in patients with psoriasis: Definitions and implications.
| العنوان: | Multi-treatment resistance to biological treatment in patients with psoriasis: Definitions and implications. |
|---|---|
| المؤلفون: | Henckens NFT; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Thomas SE; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands. |
| مؤلفون مشاركون: | BioCAPTURE Network |
| المصدر: | Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 May 31. Date of Electronic Publication: 2024 May 31. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Oxford : Wiley-Blackwell Original Publication: Amsterdam ; New York : Elsevier Science Publishers, c1992- |
| References: | Mastorino L, Roccuzzo G, Dapavo P, Siliquini N, Avallone G, Rubatto M, et al. Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult‐to‐treat population. Br J Dermatol. 2022;187(2):263–265. Loft N, Egeberg A, Rasmussen MK, Bryld LE, Nissen CV, Dam TN, et al. Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study. J Eur Acad Dermatol Venereol. 2022;36(8):1284–1291. Jin JQ, Cronin A, Roberts‐Toler C, Yeroushalmi S, Hadeler E, Spencer RK, et al. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: a 2015‐2022 prospective cohort analysis of the CorEvitas psoriasis registry. J Am Acad Dermatol. 2023;89(5):974–983. Hadeler E, Kumar S, Yeroushalmi S, Hong J, Wallace E, Han G, et al. Factors associated with multi‐biologic use in psoriasis patients at an academic medical center and review of biologic survival. J Psoriasis Psoriatic Arthritis. 2023;8(1):11–18. Yamauchi PS, Bissonnette R, Teixeira HD, Valdecantos WC. Systematic review of efficacy of anti‐tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti‐TNF agent. J Am Acad Dermatol. 2016;75(3):612–618.e6. Loft N, Halling AS, Egeberg A, Skov L. Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: a systematic review and meta‐analysis. J Am Acad Dermatol. 2021;84(1):130–138. Murphy MJ, Cohen JM, Vesely MD, Damsky W. Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis. J Am Acad Dermatol. 2022;86(5):1080–1091. Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini AA, et al. TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nat Commun. 2018;9(1):25. |
| فهرسة مساهمة: | Investigator: ME Otero; PPM van Lumig; PM Ossenkoppele; IM Haeck; JHJ Hendricksen-Roelofzen; JEM Körver; SRP Dodemont; RA Tupker; MAM Berends; RJ Lindhout; RRMC Keijsers; AM Oostveen; B Peters; JM Mommers; MBA van Doorn; M Tjioe; WR Veldkamp; ALA Kuijpers; MM Kleinpenning |
| تواريخ الأحداث: | Date Created: 20240531 Latest Revision: 20240531 |
| رمز التحديث: | 20240531 |
| DOI: | 10.1111/jdv.20133 |
| PMID: | 38818854 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1468-3083 |
|---|---|
| DOI: | 10.1111/jdv.20133 |